MedPath

TAKEDA PHARMACEUTICALS AMERICA, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

42

FDA:42

Drug Approvals

RIXUBIS

Approval Date
Apr 7, 2025
FDA

Livtencity

Approval Date
Mar 28, 2024
FDA

Entyvio

Approval Date
Mar 28, 2024
FDA

Iclusig

Approval Date
Mar 26, 2024
FDA

Gattex

Approval Date
Feb 28, 2024
FDA

Eohilia

Approval Date
Feb 9, 2024
FDA

Firazyr

Approval Date
Jan 19, 2024
FDA

Amitiza

Approval Date
Jan 18, 2024
FDA

Agrylin

Approval Date
Dec 29, 2023
FDA

Colcrys

Approval Date
Dec 29, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.